SpectraScience (SCIE) stock price, revenue, and financials

SpectraScience market cap is $443.1 k, and annual revenue was $5.15 k in FY 2016

$443.1 K

SCIE Mkt cap, 12-Aug-2020
SpectraScience Net income (Q3, 2017)-1.5 M
SpectraScience EBIT (Q3, 2017)-396.5 K
SpectraScience Cash, 30-Sept-201727.9 K
SpectraScience EV528.2 K

SpectraScience Income Statement

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

26.7k461.3k240.0k6.6k5.2k

Revenue growth, %

(22%)

Cost of goods sold

37.5k313.1k125.4k8.1k602.0199.4k

Gross profit

(10.7k)148.2k114.6k(8.1k)6.0k(194.3k)

Gross profit Margin, %

(40%)32%48%91%(3772%)

Sales and marketing expense

568.7k431.3k267.8k374.8k294.4k368.4k

R&D expense

1.7m1.1m644.1k924.4k719.2k636.6k

General and administrative expense

2.5m2.9m1.9m1.4m1.5m1.2m

Operating expense total

4.8m4.5m2.8m2.7m2.5m2.2m

EBIT

(4.8m)(4.3m)(2.7m)(2.7m)(2.5m)(2.4m)

EBIT margin, %

(17833%)(937%)(1138%)(37627%)(47460%)

Interest expense

5.5k293.2k17.9k1.8m1.2m2.0m

Income tax expense

Net Income

(4.8m)(9.1m)(2.7m)(4.5m)(3.6m)(4.5m)

SpectraScience Balance Sheet

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Cash

250.7k90.2k236.6k223.5k127.5k3.6k

Accounts Receivable

26.7k60.0k7.1k950.0

Prepaid Expenses

24.5k191.0k174.9k244.2k284.3k

Inventories

367.8k202.1k247.4k283.6k111.9k

Current Assets

669.8k648.9k801.1k859.0k611.2k361.8k

PP&E

244.3k85.6k15.9k3.7k316.0

Total Assets

3.3m2.4m2.3m2.2m1.9m1.4m

Accounts Payable

695.8k861.7k1.0m836.1k941.1k1.3m

Short-term debt

1.0m2.3m3.9m5.8m

Current Liabilities

4.0m4.9m6.6m8.9m10.8m

Total Debt

1.0m2.3m3.9m138.0k

Total Liabilities

841.2k

Common Stock

1.1m1.5m1.7m1.9m4.3m

Additional Paid-in Capital

30.9m35.5m37.1m39.5m38.2m34.6m

Retained Earnings

(29.5m)38.6m(41.4m)(45.9m)(49.5m)(54.0m)

Total Equity

2.5m(1.6m)(2.6m)(4.4m)(7.0m)

Debt to Equity Ratio

0 x

Debt to Assets Ratio

0.1 x

Financial Leverage

1.3 x-1.5 x-0.9 x-0.5 x-0.3 x

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

2.6m1.4m1.0m185.3k65.5k237.2k5.4k238.5k96.3k443.8k43.6k70.0k42.2k55.1k1.8k27.9k1.9k100.0k25.027.9k

Accounts Receivable

26.7k312.8k152.2k120.0k30.0k950.0950.0

Prepaid Expenses

17.0k25.5k26.5k11.6k120.0k175.2k148.4k223.3k159.1k135.6k201.8k228.9k203.6k308.3k247.4k213.2k318.5k225.6k191.3k187.5k

Inventories

485.5k616.7k444.8k342.4k276.3k205.5k144.0k120.6k291.1k316.2k316.7k283.9k289.2k183.8k143.5k159.7k157.6k97.4k97.4k97.4k

Current Assets

3.1m2.0m2.2m1.1m746.2k901.9k542.9k657.5k643.3k1.0m672.0k661.3k619.4k645.7k392.7k401.8k479.0k423.0k288.8k312.8k

PP&E

25.3k170.3k214.0k167.6k121.8k67.2k48.8k32.0k9.0k7.2k5.4k2.8k2.0k1.2k

Total Assets

5.7m4.7m4.8m3.6m3.1m2.6m2.2m2.2m2.1m2.5m2.1m2.0m1.9m2.0m1.7m1.7m1.7m1.4m1.2m1.2m

Accounts Payable

221.5k504.2k596.0k717.1k728.1k897.3k1.1m1.0m839.5k977.1k786.1k850.3k944.9k792.9k1.1m1.1m1.2m1.5m1.8m1.8m

Short-term debt

390.4k1.5m1.0m854.7k1.5m2.1m2.9m3.5m3.9m4.4m4.8m5.6m6.1m6.2m6.4m6.2m6.3m6.4m

Current Liabilities

3.1m6.3m3.4m6.5m6.3m5.8m7.5m8.3m6.5m7.8m8.4m8.6m10.4m10.4m11.0m11.1m12.0m12.8m

Total Debt

390.4k1.5m1.0m854.7k1.5m2.1m2.9m3.5m3.9m4.4m115.0k115.0k138.0k6.2m138.0k6.2m113.0k113.0k

Total Liabilities

465.6k547.4k5.3m9.6m6.5m

Common Stock

1.1m1.1m1.1m1.1m1.4m1.6m1.6m1.6m1.7m1.7m1.7m2.0m2.0m2.0m6.7m6.7m7.4m14.1m19.6m48.2m

Additional Paid-in Capital

30.7m30.8m31.0m31.1m34.3m35.8m36.2m36.5m37.5m38.3m38.6m39.7m39.8m39.9m36.1m36.1m35.7m29.8m24.4m(3.5m)

Retained Earnings

(26.6m)(27.8m)(32.7m)(38.2m)(39.1m)41.2m(41.9m)(41.7m)(44.6m)(45.8m)(44.8m)(47.6m)(48.3m)(48.5m)(51.6m)(51.6m)(52.4m)(55.0m)(56.2m)(57.8m)

Total Equity

5.2m4.1m(546.8k)(6.0m)(3.4m)(3.9m)(4.1m)(3.6m)(5.4m)(5.8m)(4.4m)(5.8m)(6.5m)(6.6m)(8.8m)(8.8m)(9.3m)(11.0m)(12.2m)(13.0m)

Debt to Equity Ratio

0 x0 x0 x0 x0 x0 x

Debt to Assets Ratio

0.1 x0.1 x0.1 x0.1 x0.1 x0.1 x

Financial Leverage

1.1 x1.1 x-8.8 x-0.6 x-0.9 x-0.7 x-0.5 x-0.6 x-0.4 x-0.4 x-0.5 x-0.3 x-0.3 x-0.3 x-0.2 x-0.2 x-0.2 x-0.1 x-0.1 x-0.1 x

SpectraScience Cash Flow

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(4.8m)(9.1m)(2.7m)(4.5m)(3.6m)(4.5m)

Depreciation and Amortization

298.2k916.8k239.3k184.0k165.8k161.3k

Accounts Receivable

(26.7k)(26.7k)18.6k60.0k(7.1k)6.1k

Inventories

123.3k(165.8k)(45.4k)(36.2k)21.7k(25.1k)

Accounts Payable

490.5k165.9k138.7k(172.9k)105.0k377.6k

Cash From Operating Activities

(3.3m)(2.9m)(1.6m)(2.4m)(1.9m)(1.5m)

Purchases of PP&E

(249.7k)(4.2k)(4.2k)(6.3k)

Cash From Investing Activities

1.7m(4.2k)(4.2k)(6.3k)

Short-term Borrowings

(15.0k)(30.0k)

Cash From Financing Activities

2.7m1.8m2.4m1.8m1.4m

Net Change in Cash

(1.5m)(160.5k)146.4k(13.1k)(96.0k)(123.9k)

Interest Paid

12.2k18.0k

Income Taxes Paid

SpectraScience Ratios

USDQ2, 2011

Financial Leverage

1.1 x